A Swedish study found that duration of nursing-home residence did not uniformly explain potentially inappropriate prescribing.
The analysis used questionnaire surveys from 2007 and 2013 involving 3,186 older residents. Overall flagged-medication prevalence differed between the two samples. Long-acting benzodiazepines showed no significant association with length of stay, while some other categories had different patterns.
Cross-sectional snapshots do not track every resident’s prescribing over time. The study lacked detailed diagnoses, treatment indications, doses, and duration. A nonsignificant relationship with residence length does not prove that the medicines were appropriate or free of harm.
For an expert report, avoid assuming that a longer stay necessarily means progressively more benzodiazepine exposure. Review the individual’s actual initiation, continuation, dose changes, and reassessment. This study supports routine medication review across stay lengths rather than a simple duration-based explanation of prescribing.
Source reviewed: Potentially inappropriate medications in relation to length of nursing home stay among older adults (PMC8783464). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Nursing-Home Benzodiazepine Patterns Varied Substantially Across Countries; Alcohol-Withdrawal Spectroscopy Linked Brain Metabolites With Benzodiazepine Requirements.